PA
BCAL icon

PharVision Advisers’s Southern California Bancorp BCAL Stock Holding History

PharVision Advisers’s Portfolio BCAL Stock Details BCAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,572
Closed -$309K – 154
2025
Q4 		$309K Buy
+16,572
New +$305K 0.16% 252

Other funds holding BCAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
FCM
FJ Capital Management Mclean, Virginia $770M AUM 28.42% 1-Year Est. Return
ECA
Endeavour Capital Advisors Greenwich, Connecticut $487M AUM 31.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFC
Banc Funds Company Chicago, Illinois $605M AUM 26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's BCAL Position: Q1 2026 in Review

PharVision Advisers sold out of Southern California Bancorp (BCAL) in Q1 2026, closing a stake of 16,572 shares — an estimated $309K sold.

PharVision Advisers first reported a position in BCAL in Q4 2025 and held it in 1 quarter. The position peaked at $309K in Q4 2025. 155 funds tracked by Wall St. Rank hold BCAL as of Q1 2026.

  • PharVision Advisers reported no remaining Southern California Bancorp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 16,572 Southern California Bancorp shares in Q1 2026, an estimated $309K.
  • PharVision Advisers first reported a position in Southern California Bancorp in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Southern California Bancorp position peaked at $309K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Southern California Bancorp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.